Hca Healthcare is a medical care facility company located in Tennessee, United States, which is part of the Healthcare sector, and is traded under the ticker HCA on the NYSE exchange.
Hca Healthcare stock last closed at $459.68, down 1.53% from the previous day, and has increased 28.14% in one year. It has overperformed other stocks in the Medical Care Facilities industry by 0.54 percentage points. Hca Healthcare stock is currently +58.52% from its 52-week low of $289.98, and -3.87% from its 52-week high of $478.19.
There are currently 228.19M HCA shares outstanding. The market capitalization of HCA is $104.90B. In the past 24 hours, 1.51M HCA shares were traded.
You will need an online brokerage account in order to access the NYSE market and buy HCA shares.
Based on our analysis, eToro is the best place to buy stocks. Here's why:
Get $10 towards your stock purchase by creating an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've chosen the right brokerage, you'll need to fill out some personal information so you can invest in HCA today.
Now that you've filled out your info on our top ranked stock trading app, you can securely and quickly fund your account:
Check out the walkthrough below to see the process of depositing funds into your investment account.
After you have chosen the best place to buy Hca Healthcare stock, it's very important to analyze their stock prior to buying, so you can wrap your head around the risk and upside.
WallStreetZen was designed to help average investors do better fundamental analysis in less time.
You can see all of the due diligence checks on HCA's stock page.
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge HCA's intrinsic value.
Using relative valuations ratios:
You can access more valuation research on HCA's stock here.
Out of 17 Wall Street analysts who give recommendations on HCA, the consensus analyst rating on HCA is a Buy
It's important to note that analyst ratings are not stock recommendations, nor are they investment advice.
Ben Hendrix, a top 17% analyst from RBC Capital maintains HCA with a buy rating and raises their HCA price target from $449.00 to $482.00, on Oct 27, 2025.
Raj Kumar, a top 35% analyst from Stephens & Co. maintains HCA with a strong buy rating and raises their HCA price target from $450.00 to $500.00, on Oct 27, 2025.
David S Macdonald, a top 12% analyst from Truist Securities maintains HCA with a strong buy rating and raises their HCA price target from $460.00 to $495.00, on Oct 27, 2025.
Truist Securities's David S Macdonald raised their price target on Hca Healthcare (NYSE: HCA) by 7.6% from $460 to $495 on 2025/10/27. The analyst maintained their Strong Buy rating on the stock.
HCA Healthcare reported its Q3 2025 earnings.
Macdonald expressed optimism about the company following a print that exceeded revenue and EPS consensus metrics.
The analyst noted that management raised its FY 2025 outlook to reflect larger supplemental payments and better core operating results.
For Q3 2025, HCA Healthcare reported:
For FY 2025, management guided:
CEO Sam Hazen commented: "Our teams continued to execute our agenda at a high level, and we remain disciplined in our efforts to improve care for our patients by increasing access, investing in advanced technology, and training our people.
"Across many operational measures, including quality and key stakeholders' satisfaction, outcomes were better.”
Michael Wiederhorn, a bottom 10% analyst from Oppenheimer maintains HCA with a buy rating and raises their HCA price target from $400.00 to $500.00, on Oct 27, 2025.
Ann Hynes, a top 9% analyst from Mizuho maintains HCA with a buy rating and raises their HCA price target from $475.00 to $505.00, on Oct 27, 2025.
You can dig deeper into what analysts are projecting on the Hca Healthcare stock forecast page.
Last year, HCA earnings were $6.34B. During the last 5 year, HCA's earnings have gone up by 21.13% per year. This was faster than the Medical Care Facilities industry average of 14.48%.
Last year, HCA revenue was $74.37B. In the past 5 year, HCA's revenue has gone up by 7.94% per year. This was faster than the Medical Care Facilities industry average of 7.89%.
You can research HCA's earnings and revenue performance here.
Over the last year, insiders at HCA have bought more shares than they have sold.
Michael S. Cuffe, EVP and Chief Clinical Officer of HCA, was the latest HCA insider to sell. They sold $1,606,670.24 worth of HCA shares on Sep 8, 2025.
Dig into more about who owns HCA shares here.
Hca Healthcare pays a dividend of 0.61%, compared to the Medical Care Facilities industry's average dividend yield of 2.93%. If you owned $1,000 worth of HCA stock, you would have received $6.13 in the past year.
Hca Healthcare dividend payments have consistently grown over the past decade but have not remained stable.
Find more data about Hca Healthcare dividend yield and history here.
One of the primary reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other community members have to say.
There are two primary order types:
Hit the Open button and eToro will place your order.
If you require additional help with investing in stocks on eToro, watch the how to video below:
Now that you own some HCA shares, you'll want to keep up with your shares.
Make a watchlist to get notified of important updates regarding your HCA stock.
To summarize, here are the 6 steps you need to take to buy Hca Healthcare stock right now:
If you are looking for a place to buy stocks, eToro is our favorite venue.
Get Started with eToro TodayIf you want to keep an eye on your new investment in Hca Healthcare, get started below.